Literature DB >> 22118936

Exploring the scope of expanding advanced nursing practice in nurse-led clinics: a multiple-case study.

Ann T Y Shiu1, Diana T F Lee, Janita P C Chau.   

Abstract

AIM: This article is a report on a study to explore the development of expanding advanced nursing practice in nurse-led clinics in Hong Kong.
BACKGROUND: Nurse-led clinics serviced by advanced practice nurses, a common international practice, have been adopted in Hong Kong since 1990s. Evaluations consistently show that this practice has good clinical outcomes and contributes to containing healthcare cost. However, similar to the international literature, it remains unclear as to what the elements of good advanced nursing practice are, and which directions Hong Kong should adopt for further development of such practice.
METHODS: A multiple-case study design was adopted with six nurse-led clinics representing three specialties as six case studies, and including two clinics each from continence, diabetes and wound care. Each case had four embedded units of analysis. They included non-participant observation of nursing activities (9 days), nurse interviews (N = 6), doctor interviews (N = 6) and client interviews (N = 12). The data were collected in 2009. Within- and cross-case analyses were conducted.
RESULTS: The cross-case analysis demonstrated six elements of good advanced nursing practice in nurse-led clinics, and showed a great potential to expand the practice by reshaping four categories of current boundaries, including community-hospital, wellness-illness, public-private and professional-practice boundaries. From these findings, we suggest a model to advance the scope of advanced nursing practice in nurse-led clinics.
CONCLUSION: The six elements may be applied as audit criteria for evaluation of advanced nursing practice in nurse-led clinics, and the proposed model provides directions for expanding such practice in Hong Kong and beyond.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22118936     DOI: 10.1111/j.1365-2648.2011.05868.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  7 in total

1.  The Role of Nursing Consultant in Iran: A Qualitative Study.

Authors:  Hojatollah Yousefi; Elaheh-Sadat Ziaee; Parastoo Golshiri
Journal:  Iran J Nurs Midwifery Res       Date:  2019 Sep-Oct

Review 2.  Nurse-led cancer care: A scope review of the past years (2003-2016).

Authors:  Xiao Bin Lai; Shirley Siu Yin Ching; Frances Kam Yuet Wong
Journal:  Int J Nurs Sci       Date:  2017-03-06

Review 3.  A review of advanced practice nursing in the United States, Canada, Australia and Hong Kong Special Administrative Region (SAR), China.

Authors:  Judith M Parker; Martha N Hill
Journal:  Int J Nurs Sci       Date:  2017-01-14

Review 4.  The necessity and possibility of implementation of nurse prescribing in China: An international perspective.

Authors:  Dong-Lan Ling; Chun-Mei Lyu; Hui Liu; Xiao Xiao; Hong-Jing Yu
Journal:  Int J Nurs Sci       Date:  2017-12-29

5.  Randomized controlled trial of a nurse-led rheumatology clinic for monitoring biological therapy.

Authors:  Ingrid Larsson; Bengt Fridlund; Barbro Arvidsson; Annika Teleman; Stefan Bergman
Journal:  J Adv Nurs       Date:  2013-06-17       Impact factor: 3.187

6.  An exploration of clinical practice in sites with and without clinical nurse or midwife specialists or advanced nurse practitioners, in Ireland.

Authors:  Imelda Coyne; Catherine M Comiskey; Joan G Lalor; Agnes Higgins; Naomi Elliott; Cecily Begley
Journal:  BMC Health Serv Res       Date:  2016-04-26       Impact factor: 2.655

7.  A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial.

Authors:  Ingrid Larsson; Bengt Fridlund; Barbro Arvidsson; Annika Teleman; Petra Svedberg; Stefan Bergman
Journal:  BMC Musculoskelet Disord       Date:  2015-11-16       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.